are compounded semaglutides going away 🚨 FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these WARNING! Attention to anyone taking/or

KEY BENEFITS

Research Summary The BPC-157/TB-500/GHK-Cu/KPV peptide blend leverages synergistic mechanisms to promote tissue repair and reduce inflammation, with evidence primarily from preclinical animal models

Individuals supportingimmune system function

Legislative authorization for the wildly popular program lapsed in late 2024, and although its direct impact had been blunted due to language permitting FDA to award PRVs until September 30, 2026 so long as the underlying products had received RPD designations before December 20, 2024, uncertainty over the programs fate was beginning to weigh on product developers and investors alike

"When shopping for healthcare becomes as easy as booking a hotel, we can eliminate decades of inefficiency, Bertolini said

J Neurosci 32(23):80748083